Erleada tablets 60mg, containing Apalutamide, are manufactured by Janssen Pharmaceutical. This medication (YJ code: 4291059F1029, 60mg 1 tablet) is an androgen receptor inhibitor indicated for the treatment of non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
Erleada tablets 60mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).